Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4030716
Return to Previous Page
4030716

Availability: In stock

DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS trifluoroacetate salt

4030716

Product No. Pack Size Available ADS InfoAnalytical Data Sheet Unit Price Online Order Price Qty
4030716.0001 1 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 315.00
CHF 292.95 (7%)
4030716.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 1,261.00
CHF 1,172.73 (7%)
Add to Wish List
Add to Compare

Details

The fluorogenic HIV-1 protease substrate DABCYL-Gaba-SQNYPIVQ-EDANS consists of an octapeptide with a fluorescent donor (EDANS) and a quenching acceptor (DABCYL), attached at the COOH- and NH₂-termini. The γ-Abu spacer was inserted to avoid potential steric hindrance of substrate binding by the bulky acceptor. This FRET substrate is cleaved by the HIV-1 protease at the Tyr-Pro bond which results in a time-dependent increase in fluorescence intensity; excitation at 340 nm, emission at 490 nm.
Catalog Number M-1865
APC Number 72-3-30
One Letter Code DABCYL-Gaba-SQNYPIVQ-EDANS
Molecular Formula C₇₃H₉₇N₁₇O₁₈S
Relative Molecular Mass 1532.74
CAS Registry Number [127134-13-8] net
Source Synthetic
Storage Conditions -20 ± 5 °C
Keywords HIV protease FRET substrate
Areas of Interest Infectious Disease
Links / Documents:
Brochures:
No brochures found.

Bachem product citations

T.Christopeit et al., Mar. Drugs, 11, 4279 (2013)
C.Bougault et al., Arthritis Rheum., 64, 3972 (2012)
L.Bannwarth et al., Biochemistry, 48, 379 (2009)
L.Bannwarth et al., J. Med. Chem., 49, 4657 (2006)
L.Bannwarth et al., J. Med. Chem., 49, 4657 (2006)
J.F.Liotard et al., Antivir. Chem. Chemother., 17, 193 (2006)
K.Sookkongwaree et al., Pharmazie, 61, 717 (2006)
J.Lindberg et al., Eur. J. Biochem., 271, 4594 (2004)
N.A.Yehia et al., Bioorg. Med. Chem. Lett., 14, 3121 (2004)
H.O.Andersson et al., Eur. J. Biochem., 270, 1746 (2003)
D.Hoffmann et al., Biol. Chem., 384, 1109 (2003)
I.Blumenzweig et al., Biochem. Biophys. Res. Commun., 292, 832 (2002)
Z.Nie et al., Cell Death Differ., 9, 1172 (2002)
B.S.Robinson et al., Antimicrob. Agents Chemother., 44, 2093 (2000)
M.S.Shearman et al., Biochemistry, 39, 8698 (2000)
M.S.Shearman et al., Biochemistry, 39, 8698 (2000)
H.J.Schramm et al., Biol. Chem., 380, 593 (1999)
H.L.Sham et al., Antimicrob. Agents Chemother., 42, 3218 (1998)
U.Nillroth et al., Antimicrob. Agents Chemother., 41, 2383 (1997)

Product citations

L.Bannwarth et al., J. Med. Chem., 49, 4657 (2006)
U.Nillroth et al., Antimicrob. Agents Chemother., 41, 2383 (1997)
M.W.Pennington et al., Peptides 1992, Proceedings of the 22nd European Peptide Symposium, Interlaken, Switzerland, p. 936, C.H.Schneider and A.N.Eberle, eds., Escom, Leiden, (1993)
E.D.Matayoshi et al., Science, 247, 954 (1990)

4030716

Enzyme Substrates Inhibitors
Retropepsin    
HIV-2 Protease